DVA
DaVita Inc.
NYSE · USHealthcareMedical - Care Facilities
$234.10-1.21%
Price as of Jul 20, 2026
DVA growth
DaVita Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +6.7%
- EBITDA
- +1.3%
- EBIT
- +1.5%
- EPS
- -1.9%
- Free cash flow
- -15.1%
- Operating cash flow
- -13.2%
Forward estimates
- Revenue
- +2.3%
- EBITDA
- +3.7%
- EPS
- +47.7%
Three-year CAGR
- Revenue
- +5.5%
- EBITDA
- +8.7%
- EBIT
- +14.5%
- Net income
- +10.0%
- EPS
- +18.2%
- Free cash flow
- +10.9%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.